Statement on litigation challenging legality of the Administration’s most favoured nation rule

Pharmaceutical Research and Manufacturers of America

4 December 2020 - Today, the Pharmaceutical Research and Manufacturers of America, the Association of Community Cancer Centers, the Global Colon Cancer Association and National Infusion Center Association filed a lawsuit in the U.S. District Court for the District of Maryland asserting that the most favoured nation interim final rule exceeds the statutory authority provided to the Centers for Medicare and Medicaid Services, raises serious constitutional questions and improperly fails to follow required rule making procedures.

Read Pharmaceutical Research and Manufacturers of America press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing